Phase 4 N=11 Treatment

Hypothyroidism Treated With Calcitonin

Hypothyroidism

Bottom Line

View on ClinicalTrials.gov: NCT03342001 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2021

Primary outcome: Primary: Modified City of Hope Quality of Life Questionnaire for Patients With Thyroid Disease — -36.33 score on a scale

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: Calcitonin (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Maryland, Baltimore
Primary completion: Jun 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Modified City of Hope Quality of Life Questionnaire for Patients With Thyroid Disease	-36.33	—

Summary

Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.

Eligibility Criteria

Inclusion Criteria

Normal TSH on levothyroxine therapy

Exclusion Criteria

pregnant or 6 months post partum
Current or previous thyroid cancer
Congenital hypothyroidism
any tobacco use
prescribed proton pump inhibitors
prescribed steroids
taking armour thyroid, naturethroid, or any dessicated thyroid hormone
Unstable medical conditions (CKD, Cirrhosis etc)
pituitary disease

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03342001). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.